Highlights and Quick Summary
- Weighted Average Shares Diluted Growth for the quarter ending June 30, 2022 was -0.0 (a -333.33% decrease compared to previous quarter)
- Year-over-year quarterly Weighted Average Shares Diluted Growth decreased by -115.76%
- Annual Weighted Average Shares Diluted Growth for 2021 was 0.03 (a -373.58% decrease from previous year)
- Annual Weighted Average Shares Diluted Growth for 2020 was -0.01 (a -50.47% decrease from previous year)
- Annual Weighted Average Shares Diluted Growth for 2019 was -0.02 (a -15.08% decrease from previous year)
Visit stockrow.com/ANIK
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Weighted Average Shares Diluted Growth of Anika Therapeutics Inc.
Most recent Weighted Average Shares Diluted Growthof ANIK including historical data for past 10 years.Interactive Chart of Weighted Average Shares Diluted Growth of Anika Therapeutics Inc.
Anika Therapeutics Inc. Weighted Average Shares Diluted Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -0.0 | 0.0 | – | – | – |
| 2021 | 0.02 | 0.03 | 0.03 | 0.01 | 0.03 |
| 2020 | -0.01 | -0.01 | 0.01 | 0.0 | -0.01 |
| 2019 | -0.02 | 0.0 | -0.06 | -0.02 | -0.02 |
| 2018 | -0.03 | -0.05 | -0.01 | -0.02 | -0.03 |
| 2017 | -0.0 | 0.0 | -0.0 | -0.02 | -0.0 |
| 2016 | -0.01 | -0.02 | -0.01 | -0.0 | -0.01 |
| 2015 | 0.0 | -0.01 | -0.01 | -0.01 | 0.0 |
| 2014 | 0.03 | 0.03 | 0.06 | 0.08 | 0.03 |
| 2013 | 0.03 | 0.03 | 0.01 | 0.02 | 0.03 |
| 2012 | 0.04 | 0.05 | 0.05 | 0.03 | 0.04 |
| 2011 | 0.01 | 0.01 | – | – | 0.01 |
Business Profile of Anika Therapeutics Inc.
Sector: Healthcare
Industry: Medical Devices